Brief: Abbott Q2 Adjusted EPS USD 1.31 Vs. IBES Estimate USD 1.28
16/07/2026 12:31
BRIEF-Abbott Q2 Adjusted EPS USD 1.31 Vs. IBES Estimate USD 1.28 Jul 16 (Reuters) - Abbott Q2 EPS USD 0.53.
- outlook FY adjusted EPS USD 5.45-5.6 vs. IBES estimate USD 5.49
Recent news on Abbott Laboratories
See all newsBrief: Abbott Announces Availability Of Panbio Covid-19/Flu A&B Self-Test In Canada
Perrigo to sell infant formula business to MeridianMade for up to $175 million
Brief: Abbott Initiates Pivotal Trial For Cephea™ Device, An Innovative Treatment For Mitral Heart Valve Disease
Corrected: German startup NVision shows new path to quantum computing chips in Nature paper
Brief: Abbott Receives FDA Approval For First Device To Treat Leaks After Heart Valve Replacement